1. Home
  2. NEO vs SPRY Comparison

NEO vs SPRY Comparison

Compare NEO & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • SPRY
  • Stock Information
  • Founded
  • NEO 2001
  • SPRY 2015
  • Country
  • NEO United States
  • SPRY United States
  • Employees
  • NEO N/A
  • SPRY N/A
  • Industry
  • NEO Precision Instruments
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEO Health Care
  • SPRY Health Care
  • Exchange
  • NEO Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • NEO 1.2B
  • SPRY 1.1B
  • IPO Year
  • NEO 1999
  • SPRY N/A
  • Fundamental
  • Price
  • NEO $10.15
  • SPRY $8.34
  • Analyst Decision
  • NEO Buy
  • SPRY Strong Buy
  • Analyst Count
  • NEO 10
  • SPRY 4
  • Target Price
  • NEO $12.56
  • SPRY $31.25
  • AVG Volume (30 Days)
  • NEO 4.9M
  • SPRY 1.7M
  • Earning Date
  • NEO 10-28-2025
  • SPRY 11-10-2025
  • Dividend Yield
  • NEO N/A
  • SPRY N/A
  • EPS Growth
  • NEO N/A
  • SPRY N/A
  • EPS
  • NEO N/A
  • SPRY N/A
  • Revenue
  • NEO $709,162,000.00
  • SPRY $112,339,000.00
  • Revenue This Year
  • NEO $10.74
  • SPRY N/A
  • Revenue Next Year
  • NEO $9.85
  • SPRY $193.13
  • P/E Ratio
  • NEO N/A
  • SPRY N/A
  • Revenue Growth
  • NEO 10.10
  • SPRY 22367.80
  • 52 Week Low
  • NEO $4.72
  • SPRY $8.14
  • 52 Week High
  • NEO $19.12
  • SPRY $18.90
  • Technical
  • Relative Strength Index (RSI)
  • NEO 57.70
  • SPRY 34.25
  • Support Level
  • NEO $9.42
  • SPRY $8.32
  • Resistance Level
  • NEO $10.75
  • SPRY $9.19
  • Average True Range (ATR)
  • NEO 0.54
  • SPRY 0.49
  • MACD
  • NEO -0.07
  • SPRY -0.07
  • Stochastic Oscillator
  • NEO 39.68
  • SPRY 14.15

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: